Promoting repeat tobacco dependence treatment: are relapsed smokers interested? [0.03%]
促进重复烟草依赖治疗的开展：复吸者对此感兴趣吗？
Steven S Fu,Melissa R Partin,Annamay Snyder et al.
Steven S Fu et al.
Background: Promotion of repeat tobacco dependence treatment among relapsed smokers interested in "recycling" (repeat quit attempt) may be a promising approach to increase quit rates. ...
Randomized Controlled Trial
The American journal of managed care. 2006 Apr;12(4):235-43. DOI: 2006
Effective diabetes care by a registered nurse following treatment algorithms in a minority population [0.03%]
注册护士依治疗方案为少数族裔糖尿病患者提供有效护理
Mayer B Davidson,Maria Castellanos,Petra Duran et al.
Mayer B Davidson et al.
Objective: To compare usual care with nurse-directed care for patients with diabetes. Study design: Randomized before-after trial. ...
Randomized Controlled Trial
The American journal of managed care. 2006 Apr;12(4):226-32. DOI: 2006
What will it take for disease management to demonstrate a return on investment? New perspectives on an old theme [0.03%]
疾病管理如何才能证明投资回报？旧主题 新视角
Ariel Linden Linden
Ariel Linden Linden
Background: Disease management programs are expected (and usually contractually required) to reduce total costs in the diseases they manage. Objectives: ...
Economic evaluation of controlled-release oxycodone vs oxycodone-acetaminophen for osteoarthritis pain of the hip or knee [0.03%]
控释氧可酮与氧可酮-对乙酰氨基酚治疗髋关节或膝关节骨关节炎疼痛的经济评价
Deborah A Marshall,Marcie E Strauss,Dan Pericak et al.
Deborah A Marshall et al.
Objective: To examine, in routine practice, the effectiveness and cost-effectiveness of oxycodone (OxyContin) compared with standard therapy for osteoarthritis pain. ...
Randomized Controlled Trial
The American journal of managed care. 2006 Apr;12(4):205-14. DOI: 2006
Toward evidence-based assessment for coverage and reimbursement of laboratory-based diagnostic and genetic tests [0.03%]
基于证据的实验室诊断和基因检测评估、涵盖范围和报销政策的应用和发展研讨会总结报告
Scott D Ramsey,David L Veenstra,Louis P Garrison Jr et al.
Scott D Ramsey et al.
Despite the pervasiveness of laboratory tests and their importance to medicine, evidence for their appropriate use often is very limited. In this article, we argue for a fundamental restructuring of the process by which laboratory tests are...
An examination of treatment patterns and costs of care among patients with benign prostatic hyperplasia [0.03%]
良性前列腺增生患者的治疗模式和医疗费用分析
Libby Black,Michael James Naslund,Thomas D Gilbert Jr et al.
Libby Black et al.
Objective: To examine utilization and costs of care for benign prostatic hyperplasia (BPH)-related services in a large cohort of commercially insured persons. ...
The cost of treating the 10 most prevalent diseases in men 50 years of age or older [0.03%]
50岁以上男性十大常见疾病的治疗成本
Thomas C Fenter,Michael James Naslund,Manan B Shah et al.
Thomas C Fenter et al.
Objective: Costs of treating the 10 most prevalent diagnosed diseases in men > or = 50 years of age were examined in hopes of identifying areas for better medical management and opportunities to decrease healthcare costs....
An assessment of the diagnosed prevalence of diseases in men 50 years of age or older [0.03%]
对50岁及以上男性患病率的评估
Muta M Issa,Thomas C Fenter,Libby Black et al.
Muta M Issa et al.
Objective: A lack of focus on certain men's health problems has led to significant morbidity and mortality in aging men. Managed care must begin to focus on the conditions that are most prevalent in this fast-growing popu...
The hidden condition: status, challenges, and opportunities in the management of enlarged prostate for managed care [0.03%]
隐秘的疾病：前列腺增生的管理中的现状、挑战和机遇
Michael James Naslund,Evelyn Chiao,Libby Black et al.
Michael James Naslund et al.
Michael James Naslund,Muta M Issa,Amy L Grogg et al.
Michael James Naslund et al.
Background: Benign prostatic hyperplasia (BPH), also referred to as enlarged prostate, is a highly prevalent condition in men aged 50 years or older. It is a progressive disease with significant morbidity from complicatio...